Not Tagged
Amphista Therapeutics
[]
our chief development officer martin pass and our vice president of drug discovery martin o rourke will be attending the annual meeting 2023 on april 14-19 at the in orlando, florida. learn more about the meeting: #aacr23 #biotech 
A global leader in the discovery and development of next generation targeted protein degradation therapeutics with the potential to treat a range of diseases.